
Nancy Karreman
@karremannancy
Research Associate @MRC_Epid interested in commercial determinants of health, ethics and policy.
ID: 1185206965745704962
http://linkedin.com/in/nancy-karreman-b02758b4 18-10-2019 14:52:24
216 Tweet
207 Followers
490 Following



really nice paper on the different ways of doing interpretive policy research in critical_policy doi.org/10.1080/194601…


We often read about negative unintended consequences of #foodpolicy, but here's a positive example from Dr Nina Rogers MRC Epidemiology Unit and colleagues ... unexpected co-benefit of soft drinks industry levy + asthma


👏Congratulations to WHO/Europe for their revealing report on the commercial determinants of health. Great contributions from MRC Epidemiology Unit expert Dr Ben Hawkins and many other colleagues from the UK. Full report here: iris.who.int/handle/10665/3…

📢 New study out! Dr Dori Patay and I attended a corporate affairs conference to gain insights from senior execs into the tactics being used but also their fears. A focus for all presenters was building & protecting a “social license to operate”. tinyurl.com/a3skh4vf 1/5



hi @drinkaware . Would you consider images to be triggers also? Like advertising images? You seem to have omitted mentioning them


New The Health Foundation blog. Tl;dr: Making a stronger economic case is v important, but realising the potential of any investment needs to focus on more than just medicines and tech, and must involve the whole of gov working together. 🧵 health.org.uk/news-and-comme…



Super pleased to see this paper out! ijhpm.com/article_4651.h… Led by the impressive Jenn Lacy-Nichols we examined how government lobbying disclosures rarely reveal who is lobbying or why. (1/6)
